ZVS101e
- Generic Name
- ZVS101e
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
ZVS101e is a recombinant adeno-associated virus vector carrying human CYP4V2 gene.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
Phase 3
Recruiting
- Conditions
- Bietti Crystalline Corneoretinal DystrophyBietti Crystalline Dystrophy
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Chigenovo Co., Ltd
- Target Recruit Count
- 62
- Registration Number
- NCT06743646
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Harbin Medical University, Haerbin, Heilongjiang, China
Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT05714904
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath